Editas Medicine wins CRISPR patent ruling from USPTO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/20/2026

1. BA
2. SPY
3. USO
4. RTX
5. AMC
6. NVDA
7. XFLT
8. GE
9. TRV
10. PSNL

Go back to Editas Medicine wins CRISPR patent ruling from USPTO
(NASDAQ: EDIT) Delayed: 2.88 -0.1 (3.36%)
Previous Close $2.98    52 Week High $43.99 
Open $2.96    52 Week Low $12.43 
Day High $3.07    P/E N/A 
Day Low $2.85    EPS $0.00 
Volume 1,399,199